Use of 5HT-1F receptor antagonists for treating anxiety disorders
申请人:ELI LILLY AND COMPANY
公开号:EP0976747A3
公开(公告)日:2000-09-13
The present invention provides a method for the treatment of prevention of anxiety disorders which comprises administering to a mammal in need of such treatment a serotonin 5-HT1F receptor antagonist.
本发明提供了一种治疗预防焦虑症的方法,包括向需要此类治疗的哺乳动物施用一种5-HT1F受体拮抗剂。
5-HT1F antagonists
申请人:Eli Lilly and Company
公开号:US06242450B1
公开(公告)日:2001-06-05
This invention provides 5-HT1f antagonists of Formula I:
where AR1, AR2, R, and R′ are as defined in the specification.
这项发明提供了化学式I中的5-HT1f拮抗剂:其中AR1、AR2、R和R'如规范中所定义。
Enantioselective Parallel Synthesis Using Polymer-Supported Chiral Co(salen) Complexes
作者:Stefan Peukert、Eric N. Jacobsen
DOI:10.1021/ol990920q
日期:1999.10.1
[GRAPHICS]The kinetic resolution of epoxides with phenols catalyzed by a polymer supported Co(salen) complex is applied to the first enantioselective catalytic synthesis of parallel libraries, The corresponding 1-aryloxy-2-alcohols are obtained in high yield, purity, and enantiomeric excess. Further elaboration with diversity elements provides highly efficient access to important classes of pharmacologically active compounds.